Tandem Diabetes Care, Inc.Tandem Diabetes Care, Inc.Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪2.82 B‬USD
−2.17USD
‪−222.61 M‬USD
‪747.72 M‬USD
‪64.07 M‬
Beta (1Y)
1.37

About Tandem Diabetes Care, Inc.

CEO
John F. Sheridan
Headquarters
San Diego
Employees (FY)
‪2.4 K‬
Founded
2006
FIGI
BBG0019V9M65
Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its products include Tandem Mobi System and t:slim X2 Insulin Pump. The company was founded by Paul M. DiPerna on January 27, 2006, and is headquartered in San Diego, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of TNDM is 43.57 USD — it has decreased by 0.21% in the past 24 hours. Watch Tandem Diabetes Care, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Tandem Diabetes Care, Inc. stocks are traded under the ticker TNDM.
TNDM stock has fallen by 5.55% compared to the previous week, the month change is a 1.40% rise, over the last year Tandem Diabetes Care, Inc. has showed a 41.32% increase.
We've gathered analysts' opinions on Tandem Diabetes Care, Inc. future price: according to them, TNDM price has a max estimate of 75.00 USD and a min estimate of 18.00 USD. Watch TNDM chart and read a more detailed Tandem Diabetes Care, Inc. stock forecast: see what analysts think of Tandem Diabetes Care, Inc. and suggest that you do with its stocks.
TNDM reached its all-time high on Jan 14, 2014 with the price of 302.50 USD, and its all-time low was 2.14 USD and was reached on Feb 9, 2018. View more price dynamics on TNDM chart.
See other stocks reaching their highest and lowest prices.
TNDM stock is 3.68% volatile and has beta coefficient of 1.37. Track Tandem Diabetes Care, Inc. stock price on the chart and check out the list of the most volatile stocks — is Tandem Diabetes Care, Inc. there?
Today Tandem Diabetes Care, Inc. has the market capitalization of ‪2.82 B‬, it has increased by 9.62% over the last week.
Yes, you can track Tandem Diabetes Care, Inc. financials in yearly and quarterly reports right on TradingView.
Tandem Diabetes Care, Inc. is going to release the next earnings report on Aug 1, 2024. Keep track of upcoming events with our Earnings Calendar.
TNDM earnings for the last quarter are −0.65 USD per share, whereas the estimation was −0.76 USD resulting in a 14.59% surprise. The estimated earnings for the next quarter are −0.54 USD per share. See more details about Tandem Diabetes Care, Inc. earnings.
Tandem Diabetes Care, Inc. revenue for the last quarter amounts to ‪192.80 M‬ USD, despite the estimated figure of ‪174.52 M‬ USD. In the next quarter, revenue is expected to reach ‪205.63 M‬ USD.
TNDM net income for the last quarter is ‪−42.72 M‬ USD, while the quarter before that showed ‪−30.00 M‬ USD of net income which accounts for −42.37% change. Track more Tandem Diabetes Care, Inc. financial stats to get the full picture.
No, TNDM doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jul 22, 2024, the company has ‪2.40 K‬ employees. See our rating of the largest employees — is Tandem Diabetes Care, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Tandem Diabetes Care, Inc. EBITDA is ‪−130.73 M‬ USD, and current EBITDA margin is −18.56%. See more stats in Tandem Diabetes Care, Inc. financial statements.
Like other stocks, TNDM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Tandem Diabetes Care, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Tandem Diabetes Care, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Tandem Diabetes Care, Inc. stock shows the neutral signal. See more of Tandem Diabetes Care, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.